References 
1. Rosenberg, S.A.: Adoptive lamunotherapy of Cancer Using Lyraphokine 
Activated Killer Cells and Reconbinant Interleukin-2. DeVita, VT, 
Heilman, S, Rosenberg, SA (eds.). Important Advances in Oncology, 1986 , 
Philadelphia, J.B. Lippincott, 1986; 55-91. 
2. Rosenberg, S.A.: The development of new immunotherapies for the treatment 
of cancer using interleukin-2. Ann. Surg . 208:121-135, 1988. 
3. Rosenberg, S.A., Lotze, M.T. , Yang, J.C., Aebersold, P.M., Linehan, W.M. , 
■¥ 
Seipp, C.A. and VJhite, D.E.: Experience with the use of high-dose interleuM 
2 in the treatment of 652 cancer patients. Ann. Surg . 210:474-485, 1989. 
4. Rosenberg, S.A. , Lotze, M.T. , Muul , L.M. , Chang, A.E., Avis, F.P., Leitman, 
S. , Linehan, W.M. , Robertson, C.N., Lee, R.E. , Rubin, J.T. , Seipp, C.A., 
Simpson, C.G. , and \Jhite, D.E.: A progress report on the treatment of 
157 patients with advanced cancer using lymphokine-activated killer cells 
and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316: 
889-897, 1987. 
5. Rosenberg, S.A., Packard, B.S., Aebersold, P.M., Solomon, D., Topalian, S.L., 
Toy, S.T., Simon, P., Lotze, M.T., Yang, J.C. , Seipp, C.A. , Cimpson, C. , 
Carter, C., Bock, S. , Schwartzentruber , D., Wei, J.P., and White, D.E.: 
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy 
of patients with metastatic melanoma. A preliminary report. N Engl J Med 
319:1676-1680, 1988. 
6. Rosenberg, S.A., Spiess, P., Lafreniere, R. : A new approach to the adoptive 
immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233: 
1318-1321, 1986. 
[284] 
Recombinant DNA Research, Volume 14 
